1/9/2008

The Federal Trade Commission said it has approved the sale of Bristol-Myers Squibb Co.'s medical-imaging unit to private-equity firm Avista Capital Partners for $525 million. The sale, which was announced by Bristol-Myers last month, is part of the company's restructuring efforts to focus on pharmaceuticals.

Related Summaries